| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 67.05B | 64.80B | 69.30B | 65.01B | 58.49B | 54.79B |
| Gross Profit | 13.14B | 13.04B | 13.61B | 14.97B | 15.12B | 16.22B |
| EBITDA | 2.58B | 3.05B | 3.54B | 3.89B | 4.64B | 4.26B |
| Net Income | -2.94B | 2.70B | 1.81B | 1.26B | 1.98B | 1.64B |
Balance Sheet | ||||||
| Total Assets | 98.03B | 101.22B | 103.02B | 103.15B | 100.46B | 97.39B |
| Cash, Cash Equivalents and Short-Term Investments | 10.78B | 8.36B | 12.85B | 10.59B | 12.16B | 7.38B |
| Total Debt | 4.53B | 9.06B | 10.96B | 18.78B | 14.91B | 11.92B |
| Total Liabilities | 24.90B | 27.38B | 30.48B | 35.01B | 32.54B | 28.93B |
| Stockholders Equity | 73.13B | 73.83B | 72.53B | 68.13B | 67.92B | 68.46B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -8.96B | 8.92B | -4.50B | 477.00M | -2.81B |
| Operating Cash Flow | 0.00 | -3.09B | 13.04B | -1.82B | 2.58B | -181.00M |
| Investing Cash Flow | 0.00 | 2.21B | -1.31B | -1.70B | 489.00M | -2.74B |
| Financing Cash Flow | 0.00 | -3.60B | -9.46B | 2.97B | 1.38B | -1.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥14.73B | 5.17 | ― | 1.91% | 2.73% | 59.02% | |
72 Outperform | ¥77.72B | 6.88 | ― | 1.55% | 5.78% | 14.23% | |
71 Outperform | ¥32.83B | 7.15 | ― | 2.84% | 6.64% | 10.48% | |
68 Neutral | ¥110.68B | 10.22 | ― | 3.97% | 3.69% | -27.70% | |
65 Neutral | ¥50.47B | -19.07 | ― | 2.12% | 3.82% | -131.02% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
49 Neutral | ¥64.67B | 32.06 | ― | 1.14% | 8.17% | 10.65% |